Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kanuka oil serum for acne vulgaris
ACTRN12619001744145Phase 2Completed
- Sponsor
- Hikurangi Bioactives
- Start
- Mar 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acne vulgaris comparing 3% Kanuka Oil Serum with Vehicle Control (2 arms). Primary endpoint: Difference in DLQI scores. Started Mar 2021; status: completed.
02
Drugs
Kanuka Oil Serum
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on ACTRN12619001744145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001744145.